510(k) Report

510(k) · Cleared

Cleared

Candela Gentlelase GL Dermatological Laser

K974381510(k) TraditionalCleared Feb 10, 199882-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Candela Corp. · GEX Powered Laser Surgical Instrument

Cleared on Feb 10, 1998 as substantially equivalent to K972767 (Candela Corp., 1997) after an 82-day review. Its family tree reaches back 2 generations to 1996. 1,178 later devices descend from it.

Decided
Feb 10, 1998
Review
82 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K963094 (1996). 1,178 later devices descend from it, 5 citing it directly.

Descendants, by year cleared 2000: 4 descendants cleared1999: 2 descendants cleared1998: 1 descendant cleared2011: 33 descendants cleared2002: 10 descendants cleared2003: 18 descendants cleared2004: 16 descendants cleared2005: 22 descendants cleared2007: 27 descendants cleared2006: 25 descendants cleared2008: 46 descendants cleared2015: 45 descendants cleared2009: 31 descendants cleared2014: 43 descendants cleared2013: 42 descendants cleared2016: 54 descendants cleared2025: 128 descendants cleared2022: 82 descendants cleared2012: 29 descendants cleared2020: 55 descendants cleared2010: 30 descendants cleared2017: 56 descendants cleared2023: 67 descendants cleared2018: 49 descendants cleared2019: 42 descendants cleared2024: 94 descendants cleared2021: 50 descendants cleared2026: 77 descendants clearedK963094 · Cynosure Photogenica LP Dermatological Vascular Lesion Laser · Cynosure, Inc. · 1996K972767 · Candela Gentlelase GL Dermatological Vascular Lesion Laser · Candela Corp. · 1997 · recalled1995200020052010201520202025
Descendants, by generation 1 generation forward: 5 descendants2 generations forward: 17 descendants3 generations forward: 44 descendants4 generations forward: 119 descendants5 generations forward: 178 descendants6 generations forward: 181 descendants7 generations forward: 205 descendants8 generations forward: 127 descendants9 generations forward: 99 descendants10 generations forward: 82 descendants11 generations forward: 55 descendants12 generations forward: 40 descendants13 generations forward: 20 descendants14 generations forward: 5 descendants15 generations forward: 1 descendant K972767 · Candela Gentlelase GL Dermatological Vascular Lesion Laser · Candela Corp. · 1997 · recalledK963094 · Cynosure Photogenica LP Dermatological Vascular Lesion Laser · Cynosure, Inc. · 19960+5+10+15
  1. Root · 2 generations backK963094 Cynosure Photogenica LP Dermatological Vascular Lesion LaserCynosure, Inc. · 1996
  2. 1 generation backK972767 Candela Gentlelase GL Dermatological Vascular Lesion LaserCandela Corp. · 1997 · Recalled
  3. This deviceK974381 Candela Gentlelase GL Dermatological LaserCandela Corp. · 1998
  4. Descendant · cites it directly · 1,062 of its ownK990417 DermacoolOptomed Corp. · 1999
  5. Descendant · 2 generations on · 1,046 of its ownK020839 Quantum, Models SR, HR, DL; Vasculight, Models SR, HR, VS, VX, DLLumenis, Inc. · 2002
  6. Descendant · 3 generations on · 856 of its ownK030527 Lumenis Family of Ipl and Combination Ipl/ND:Yag SystemsLumenis · 2003
  7. Descendant · cites it directly · 811 of its ownK981351 Candela Gentlelase GL Dermatological LaserCandela Corp. · 1998
  8. Descendant · 3 generations on · 756 of its ownK030342 Lumenis Family of Ipl Systems and Combination Ipl/ND:Yag SystemsLumenis, Ltd. · 2003 · Recalled

Showing 5 of 1,178 descendants. See all descendants

Descendants cleared per year

1998: 11999: 22000: 42002: 102003: 182004: 162005: 222006: 252007: 272008: 462009: 312010: 302011: 332012: 292013: 422014: 432015: 452016: 542017: 562018: 492019: 422020: 552021: 502022: 822023: 672024: 942025: 1282026: 77
1998high 128 (2025) · low 0 (2001)2026

Most influential descendants

Showing 5 of 1,178 · See all
  • K990417DermacoolOptomed Corp. · 1999 · cites it directly1,062descendants
  • K020839Quantum, Models SR, HR, DL; Vasculight, Models SR, HR, VS, VX, DLLumenis, Inc. · 2002 · 2 generations on1,046descendants
  • K030527Lumenis Family of Ipl and Combination Ipl/ND:Yag SystemsLumenis · 2003 · 3 generations on856descendants
  • K981351Candela Gentlelase GL Dermatological LaserCandela Corp. · 1998 · cites it directly811descendants
  • K030342Lumenis Family of Ipl Systems and Combination Ipl/ND:Yag SystemsLumenis, Ltd. · 2003 · 3 generations on756descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K963094Cynosure Photogenica LP Dermatological Vascular Lesion LaserCynosure, Inc.1996—
−1K972767Candela Gentlelase GL Dermatological Vascular Lesion LaserCandela Corp.19971
0 (this device)K974381Candela Gentlelase GL Dermatological LaserCandela Corp.1998—
+1K990417DermacoolOptomed Corp.1999—
+2K020839Quantum, Models SR, HR, DL; Vasculight, Models SR, HR, VS, VX, DLLumenis, Inc.2002—
+3K030527Lumenis Family of Ipl and Combination Ipl/ND:Yag SystemsLumenis2003—
+1K981351Candela Gentlelase GL Dermatological LaserCandela Corp.1998—
+3K030342Lumenis Family of Ipl Systems and Combination Ipl/ND:Yag SystemsLumenis, Ltd.20031

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199810
199920
200040
2002100
2003180
2004160
2005220
2006250
2007270
2008460
2009310
2010300
2011330
2012290
2013420
2014430
2015450
2016540
2017560
2018490
2019420
2020550
2021500
2022820
2023670
2024940
20251280
2026770
FIG. 1 — Lineage of K974381, 1996–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K972767Candela Gentlelase GL Dermatological Vascular Lesion Laser
Cleared while this submission was under review
Summary page 1
…and Plastic Surgery and in Dermatology) Common Name: Dermatology Laser, Long pulse Alexandrite Laser Predicate Device: Candela Gentlelase GL laser cleared under 510(k) 972767. The Candela (Modified) Gentlelase GL Laser utilizes an Alexandrite rod (crystal) which emits pulsed energy at 755 nanometers in…
Candela Corp.19971
*—Candela Dynamic Cooling Device
Named without a submission number
—

Also cleared against K972767: 2 other devices →

What descends from it? (1,178)

See all 1,178

5 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K990417DermacoolOptomed Corp.19991,062
K981351Candela Gentlelase GL Dermatological LaserCandela Corp.1998811
K994260Candela Gentlelase GL Dermatological LaserCandela Corp.2000258
K984601Candela Gentlelase II Dermatological LaserCandela Corp.1999110
K111144Candela Gentlelase Family of LasersCandela Corp.201191

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 2 years and passes through 2 companies; a new generation was cleared every 12 months on median.
  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K990417 (Optomed Corp., 1999) has gone furthest, with 1,062 descendants of its own.
  • 2 other devices also cite its predicate K972767.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

The Candela Gentlelase GL Dermatology Laser is indicated for the following uses:

1. the photocoagulation of dermatological vascular lesions.

The Candela GentleLase GL Dermatology Laser includes an integrated Dynamic Cooling Device, which is indicated for:

1. the reduction of pain.

2. cooling of skin prior to laser treatment.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K974381: Candela Gentlelase GL Dermatological Laser.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K974381

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026